What makes tumours tick? Genomics pave the way for tailored treatments
by SA Mathieson from on (#1D8D1)
Advances in genetic testing are enabling healthcare professionals to personalise treatments for diseases and conditions including cancer, diabetes and HIV
Breakthroughs in genomic medicine are helping researchers to devise a new generation of personalised treatments for a range of diseases and conditions, including cancer, diabetes and HIV.
The cost of sequencing a human genome has fallen from $95m (66m) in 2001 to just $1,345 (870), according to the US National Human Genome Research Institute. This is enabling professionals to tailor treatments based on the results of genetic tests.